CD34 and acute myeloid leukemia: MLL and NUP98 gene rearrangements share a poor prognosis in patients with AML and a fairly specific set of in vitro effects on primary human CD34+ cells, most prominent among which is their profound effect on the number and differentiation of erythroid precursors.